|
|
|
|
||
North and Central AmericaIf the USA has 14-17K patients with NTM Mac, why haven't we looked at Canada and Mexico as possible markets? I would think these countries would have similar statistics on infections. The EU is the next target market but I am curious if North America might have more patients. Anyone care to comment? |
return to message board, top of board |